10. July 2018
Future Market Insights (FMI) delivers key insights on the global biologic excipients market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. Global Biologic Excipients Market:...
27. July 2017
Orally disintegrating tablets (ODTs), also known as orodispersible tablets, are unique dosage forms formulated to improve their in vivo disintegration and dissolution rates. It is a big challenge to ODT producers to achieve a minimum disintegration time while keeping formulation simple and robust.
21. March 2017
New product offerings are low endotoxin, multi-compendial-grade materials for cell culture and biologic drug formulations. These products extend Roquette's commitment to helping customers save and sustain patients’ lives. "As a long-time leader in excipients and active ingredients for the pharmaceutical market, Roquette is proud to be part of this major therapeutic progress and is excited to introduce several new products in the US, Europe, and Asia," said Paul Smaltz, VP of Global Business...
26. October 2016
The article describes the main challenges encountered during the formulation of parenteral preparations, as well as Roquette’s solutions meeting the formulator’s needs. Author: Dr Elham Blouet, Global market manager Injectable and Dialysis, Global Business Unit Pharma & Health, ROQUETTE. Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are sterile preparations...
22. July 2016
In this piece, Carmen Popescu, PhD, Senior Project Coordinator, Roquette, provides an overview of the Orally Disintegrating Tablet (ODT) landscape, describing how these dosage forms can be used to improve and differentiate drug products, different manufacturing methods and how this class of oral delivery system might be applied in the future. Link to ONdrugDelivery Magazine
08. March 2016
Roquette Freres' plant in Lestrem, France, has earned EXCiPACT certification for Good Manufacturing Practice (GMP) from SGS France, one of EXCIPACT’s internationally-recognised certification bodies. The certificate covers the design, production and storage of excipients made from amylaceous substances such as certain starches and glucoses; sorbitol, maltitol, mannitol and xylitol powders; and maltitol solutions. This is the fifth site in France to receive EXCiPACT Certification since 2013 and...
16. December 2015
The use of β-CDs can help to overcome one of the main challenges in drug delivery: guaranteeing the bioavailability of APIs, especially when they are poorly soluble and/or with a limited gastrointestinal permeability. To improve aqueous solubility and thus the therapeutic effectiveness of such compounds, a number of formulation strategies have already been largely tested. It is a big challenge to find the right solubilization tool for these active ingredients. More
24. June 2015
To find the right solubilization tool for poorly soluble active ingredients is a big challenge. Want to know how to increase the aqueous solubility of your API and its physico-chemical stability?Why to choose β-Cyclodextrins as a solubilization tool? Discover all you need to know to successfully complexate your active ingredient with β-Cyclodextrins Paper Download